Literature DB >> 15479801

trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors.

Frank Scholle1, Yvette A Girard, Qizu Zhao, Stephen Higgs, Peter W Mason.   

Abstract

A trans-packaging system for West Nile virus (WNV) subgenomic replicon RNAs (repRNAs), deleted for the structural coding region, was developed. WNV repRNAs were efficiently encapsidated by the WNV C/prM/E structural proteins expressed in trans from replication-competent, noncytopathic Sindbis virus-derived RNAs. Infectious virus-like particles (VLPs) were produced in titers of up to 10(9) infectious units/ml. WNV VLPs established a single round of infection in a variety of different cell lines without production of progeny virions. The infectious properties of WNV and VLPs were indistinguishable when efficiencies of infection of a number of different cell lines and inhibition of infection by neutralizing antibodies were determined. To investigate the usefulness of VLPs to address biological questions in vivo, Culex pipiens quinquefasciatus mosquitoes were orally and parenterally infected with VLPs, and dissected tissues were analyzed for WNV antigen expression. Antigen-positive cells in midguts of orally infected mosquitoes were detected as early as 2 days postinfection and as late as 8 days. Intrathoracic inoculation of VLPs into mosquitoes demonstrated a dose-dependent pattern of infection of secondary tissues and identified fat body, salivary glands, tracheal cells, and midgut muscle as susceptible WNV VLP infection targets. These results demonstrate that VLPs can serve as a valuable tool for the investigation of tissue tropism during the early stages of infection, where virus spread and the need for biosafety level 3 containment complicate the use of wild-type virus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479801      PMCID: PMC523254          DOI: 10.1128/JVI.78.21.11605-11614.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.

Authors:  S Pincus; P W Mason; E Konishi; B A Fonseca; R E Shope; C M Rice; E Paoletti
Journal:  Virology       Date:  1992-03       Impact factor: 3.616

2.  Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3.

Authors:  M Lobigs
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

3.  Formation of the flavivirus envelope: role of the viral NS2B-NS3 protease.

Authors:  V F Yamshchikov; R W Compans
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

4.  Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions.

Authors:  J Schalich; S L Allison; K Stiasny; C W Mandl; C Kunz; F X Heinz
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies.

Authors:  S M Amberg; A Nestorowicz; D W McCourt; C M Rice
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.

Authors:  K V Pugachev; P W Mason; R E Shope; T K Frey
Journal:  Virology       Date:  1995-10-01       Impact factor: 3.616

7.  Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs.

Authors:  P J Bredenbeek; I Frolov; C M Rice; S Schlesinger
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

8.  Replication and tissue tropism of the alphavirus Sindbis in the mosquito Aedes albopictus.

Authors:  D F Bowers; B A Abell; D T Brown
Journal:  Virology       Date:  1995-09-10       Impact factor: 3.616

9.  Potential high-throughput assay for screening inhibitors of West Nile virus replication.

Authors:  Michael K Lo; Mark Tilgner; Pei-Yong Shi
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Vector competence of Aedes albopictus and Ae. aegypti (Diptera: Culicidae) to dengue 1 virus on Taiwan: development of the virus in orally and parenterally infected mosquitoes.

Authors:  W J Chen; H L Wei; E L Hsu; E R Chen
Journal:  J Med Entomol       Date:  1993-05       Impact factor: 2.278

View more
  60 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Tissue tropism and neuroinvasion of West Nile virus do not differ for two mouse strains with different survival rates.

Authors:  Ashley N Brown; Kim A Kent; Corey J Bennett; Kristen A Bernard
Journal:  Virology       Date:  2007-08-06       Impact factor: 3.616

3.  Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane.

Authors:  Christophe Hourioux; Malika Ait-Goughoulte; Romuald Patient; Delphine Fouquenet; Fabienne Arcanger-Doudet; Denys Brand; Annette Martin; Philippe Roingeard
Journal:  Cell Microbiol       Date:  2006-12-06       Impact factor: 3.715

4.  Host alternation of chikungunya virus increases fitness while restricting population diversity and adaptability to novel selective pressures.

Authors:  Lark L Coffey; Marco Vignuzzi
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

5.  West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection.

Authors:  Carl W Davis; Hai-Yen Nguyen; Sheri L Hanna; Melissa D Sánchez; Robert W Doms; Theodore C Pierson
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.

Authors:  Camilo Ansarah-Sobrinho; Steevenson Nelson; Christiane A Jost; Stephen S Whitehead; Theodore C Pierson
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

7.  High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.

Authors:  Francesc Puig-Basagoiti; Tia S Deas; Ping Ren; Mark Tilgner; David M Ferguson; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

8.  An influenza virus replicon system in yeast identified Tat-SF1 as a stimulatory host factor for viral RNA synthesis.

Authors:  Tadasuke Naito; Yoshihiko Kiyasu; Kenji Sugiyama; Ayumi Kimura; Ryosuke Nakano; Akio Matsukage; Kyosuke Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

9.  West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction.

Authors:  Jason R Wilson; Paola Florez de Sessions; Megan A Leon; Frank Scholle
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

10.  Transcellular transport of West Nile virus-like particles across human endothelial cells depends on residues 156 and 159 of envelope protein.

Authors:  Rie Hasebe; Tadaki Suzuki; Yoshinori Makino; Manabu Igarashi; Satoko Yamanouchi; Akihiko Maeda; Motohiro Horiuchi; Hirofumi Sawa; Takashi Kimura
Journal:  BMC Microbiol       Date:  2010-06-08       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.